System Transmission

Top Signal

100#1 JOB

Activity

2191Ripe

+952 today

System

Live1m

Terminal Asset View

stockNASDAQ

ARVN

$12.18-2.40%

Arvinas Inc

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

13Overripe

Live Analysis Active

Company Mission

Arvinas Inc creates drugs that break down harmful proteins inside the body to treat diseases like cancer. It works with big pharmaceutical companies to develop these medicines and makes money from research deals and future sales if the drugs are approved. This helps patients by offering new treatment options that target diseases at a cellular level.

ARV

Industry Context

The biotech industry focuses on developing new medical treatments using advanced science, often involving high risks and rewards as companies test experimental drugs. Investors watch for clinical trial results and partnerships, which can cause big price swings.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

52Matrix

Market Momentum

41.0— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-2.40%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ARVN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 10:07 PM UTC

As-of 03-14-2026 21:52 UTC

Develops drugs that target disease-causing proteins for degradation and earns revenue from pharmaceutical partnerships and milestone payments.

Price is consolidating in a tight range on the weekly chart, suggesting energy is building for the next significant move showing consolidation.

Biotech sector is volatile with high investor interest in novel treatments, making consolidation patterns like this a key watch item for, suggesting.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...